Insulet (PODD) Competitors

Insulet (NASDAQ:PODD) and Becton, Dickinson and Company (NYSE:BDX) are both large-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, valuation, risk, institutional ownership, analyst recommendations, media sentiment, community ranking, earnings and profitability.

Is PODD or BDX more profitable?

Insulet has a net margin of 20.19% compared to Becton, Dickinson and Company's net margin of 8.47%. Insulet's return on equity of 24.46% beat Becton, Dickinson and Company's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Insulet	20.19%	24.46%	8.33%
Becton, Dickinson and Company	8.47%	15.74%	7.29%

Which has higher valuation & earnings, PODD or BDX?

Becton, Dickinson and Company has higher revenue and earnings than Insulet. Becton, Dickinson and Company is trading at a lower price-to-earnings ratio than Insulet, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Insulet	$2.07B	8.62	$206.30M	$5.79	43.94
Becton, Dickinson and Company	$20.64B	2.81	$1.71B	$6.02	33.53

Do analysts prefer PODD or BDX?

Insulet presently has a consensus price target of $292.06, indicating a potential upside of 14.81%. Becton, Dickinson and Company has a consensus price target of $275.71, indicating a potential upside of 36.59%. Given Becton, Dickinson and Company's stronger consensus rating and higher probable upside, analysts plainly believe Becton, Dickinson and Company is more favorable than Insulet.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Insulet	0 Sell rating(s)	3 Hold rating(s)	14 Buy rating(s)	0 Strong Buy rating(s)	2.82
Becton, Dickinson and Company	0 Sell rating(s)	0 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	3.00

Does the MarketBeat Community prefer PODD or BDX?

Insulet received 132 more outperform votes than Becton, Dickinson and Company when rated by MarketBeat users. Likewise, 66.40% of users gave Insulet an outperform vote while only 62.42% of users gave Becton, Dickinson and Company an outperform vote.

Company	Underperform	Outperform
Insulet	Outperform Votes 735 66.40%	Underperform Votes 372 33.60%
Becton, Dickinson and Company	Outperform Votes 603 62.42%	Underperform Votes 363 37.58%

Do insiders & institutionals believe in PODD or BDX?

87.0% of Becton, Dickinson and Company shares are owned by institutional investors. 0.5% of Insulet shares are owned by company insiders. Comparatively, 0.4% of Becton, Dickinson and Company shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Does the media prefer PODD or BDX?

In the previous week, Becton, Dickinson and Company had 21 more articles in the media than Insulet. MarketBeat recorded 39 mentions for Becton, Dickinson and Company and 18 mentions for Insulet. Insulet's average media sentiment score of 1.27 beat Becton, Dickinson and Company's score of 1.01 indicating that Insulet is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Insulet	14 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Becton, Dickinson and Company	26 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	1 Negative mention(s)	1 Very Negative mention(s)	Positive

Which has more risk & volatility, PODD or BDX?

Insulet has a beta of 1.3, indicating that its stock price is 30% more volatile than the S&P 500. Comparatively, Becton, Dickinson and Company has a beta of 0.35, indicating that its stock price is 65% less volatile than the S&P 500.

Summary

Insulet beats Becton, Dickinson and Company on 11 of the 18 factors compared between the two stocks.